ASH 2018 CAR T Cells: 'Validation That They Keep Living and Keep Working' New longer-term data on CAR T cells from pivotal clinical trials show durable responses, with some patients remaining in ...
The autologous CAR-T cell therapy MB-105 has received regenerative medicine advanced therapy (RMAT) designation from the FDA ...
The U.S. Food and Drug Administration (FDA) has granted a regenerative medicine advanced therapy designation to MB-105, a CD5 ...
Genmab A/S (Nasdaq: GMAB) todayannounced new results from the Phase 1b/2 EPCORE® NHL-2 trial evaluating fixed-duration epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback